MIRANasdaqPharmaceutical Preparations
MIRA PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.64+0.01 (+1.55%)
Close on Oct 19, 2026
- Market cap
- $26.98M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.9779 (−60.36%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $26.98M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.31
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$9.48M
- EPS, diluted
- -$1.39
- Book value per share
- $0.19
- Diluted shares
- 42M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Net income
-$9.48M
EPS, diluted
-$1.39
Reported periodTrailing twelve months